Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arduino A Mangoni

Showing results (1-10 of 378) with videos related to

Pageof 38
Sort By:
Current Clinical Pharmacology|February 11, 2016
EDITORIAL: Repurposing Niacin as Antiplatelet Drug?Arduino A Mangoni
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2012
Predicting and detecting adverse drug reactions in old age: challenges and opportunitiesArduino A Mangoni
Current Clinical Pharmacology|April 8, 2014
Harmonization in Pharmacoepidemiological Studies: (Twi)Light at the End of the Tunnel?Arduino A Mangoni
Age and Ageing|January 9, 2018
Temporal changes in medication use and disease management in old age: where does it all end?Arduino A Mangoni
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 18, 2006
Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials?Arduino A Mangoni
Frontiers in Medicine|February 24, 2015
Geriatric medicine in an aging society: up for a challenge?Arduino A Mangoni
Drugs & Aging|December 6, 2005
Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerationsArduino A Mangoni
Hypertension (Dallas, Tex. : 1979)|January 28, 2004
Diastolic and pulse pressure: the old and the new?Arduino A Mangoni
Advances in Clinical Chemistry|October 7, 2009
The emerging role of symmetric dimethylarginine in vascular diseaseArduino A Mangoni
Expert Review of Clinical Pharmacology|November 26, 2011
Assessing the adverse effects of antimuscarinic drugs in older patients: which way forward?Arduino A Mangoni
Pageof 38

Showing results (1-10 of 378) with videos related to

Sort By:
Pageof 38
Current Clinical Pharmacology|February 11, 2016
EDITORIAL: Repurposing Niacin as Antiplatelet Drug?Arduino A Mangoni
Expert Opinion on Drug Metabolism & Toxicology|April 20, 2012
Predicting and detecting adverse drug reactions in old age: challenges and opportunitiesArduino A Mangoni
Current Clinical Pharmacology|April 8, 2014
Harmonization in Pharmacoepidemiological Studies: (Twi)Light at the End of the Tunnel?Arduino A Mangoni
Age and Ageing|January 9, 2018
Temporal changes in medication use and disease management in old age: where does it all end?Arduino A Mangoni
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 18, 2006
Folic acid, inflammation, and atherosclerosis: false hopes or the need for better trials?Arduino A Mangoni
Frontiers in Medicine|February 24, 2015
Geriatric medicine in an aging society: up for a challenge?Arduino A Mangoni
Drugs & Aging|December 6, 2005
Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerationsArduino A Mangoni
Hypertension (Dallas, Tex. : 1979)|January 28, 2004
Diastolic and pulse pressure: the old and the new?Arduino A Mangoni
Advances in Clinical Chemistry|October 7, 2009
The emerging role of symmetric dimethylarginine in vascular diseaseArduino A Mangoni
Expert Review of Clinical Pharmacology|November 26, 2011
Assessing the adverse effects of antimuscarinic drugs in older patients: which way forward?Arduino A Mangoni
Pageof 38